Market Overview

UPDATE: Citigroup Downgrades Centene to Neutral on Limited Upside Potential

Related CNC
Credit Suisse Raises Centene Price Target Following Investors Day
Top 4 NYSE Stocks In The Health Care Plans Industry With The Highest ROA

Citigroup downgraded Centene (NYSE: CNC) from Buy to Neutral and maintained its $45 price target.

Citigroup noted, "After a 6% move on Tuesday, and with the stock up 75% from its June low, we're taking a step back on Centene. Even with $15 billion in revenue (that's a 50% increase relative to projected 2013 revenue of $10 billion), and a 1.5% net margin, Centene would earn around $4/share, which at a 12x multiple would value the company at $48, only modestly higher than the current price."

Centene closed at $44.99 on Tuesday.

Latest Ratings for CNC

DateFirmActionFromTo
Dec 2014CitigroupMaintainsSell
Dec 2014Credit SuisseMaintainsOutperform
Dec 2014Credit SuisseMaintainsOutperform

View More Analyst Ratings for CNC
View the Latest Analyst Ratings

Posted-In: CitigroupAnalyst Color Downgrades Analyst Ratings

 

Related Articles (CNC)

Around the Web, We're Loving...

Get Benzinga's Newsletters